Leo Metz counsels private and public companies of all growth stages on various corporate matters, including venture capital financings, mergers and acquisitions, cross-border transactions, corporate governance, and public offerings.
Atsena Therapeutics Announces Oversubscribed $150 Million Series C
April 2, 2025
Cooley advised Atsena Therapeutics, a clinical-stage gene therapy company developing best-in-class treatments for the reversal or prevention of blindness from inherited retinal diseases, on the close of its oversubscribed $150 million Series C financing.
Cooley advised Halcyon on its $100 million Series C funding. Partner Derek Colla led the Cooley team advising Halcyon, an organization devoted to defeating ransomware through prevention and resilience by way of a proprietary technology that captures encryption keys, enabling organizations to recover from attacks in minutes without paying ransom.
Cooley advised Lightning AI on its $50 million equity investment. Partner Derek Colla led the Cooley team advising Lightning AI, a company that simplifies and accelerates artificial intelligence development by providing a unified platform for training, deploying and scaling it.
Cooley advised Lightning AI, creator of the PyTorch Lightning framework, on its $50 million equity investment from Cisco Investments, J.P. Morgan, K5 Global and NVIDIA, bringing its total funding to $103 million.
Cooley advised Boldend, a top cyber automation company developing software solutions that enhance and scale cyber capabilities, on its acquisition by SIXGEN, a full-spectrum provider of cyber products, operations and solutions to the US national security and critical infrastructure sectors.
